Cargando…
Retraction: Aclarubicin regulates glioma cell growth and DNA damage through the SIRT1/PI3K/AKT signaling pathway
Retraction of ‘Aclarubicin regulates glioma cell growth and DNA damage through the SIRT1/PI3K/AKT signaling pathway’ by Jun-Feng Huo et al., RSC Adv., 2019, 9, 28775–28782, DOI: 10.1039/C9RA05572J.
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694638/ https://www.ncbi.nlm.nih.gov/pubmed/35427023 http://dx.doi.org/10.1039/d1ra90038b |
_version_ | 1784619399481655296 |
---|---|
author | Fisher, Laura |
author_facet | Fisher, Laura |
author_sort | Fisher, Laura |
collection | PubMed |
description | Retraction of ‘Aclarubicin regulates glioma cell growth and DNA damage through the SIRT1/PI3K/AKT signaling pathway’ by Jun-Feng Huo et al., RSC Adv., 2019, 9, 28775–28782, DOI: 10.1039/C9RA05572J. |
format | Online Article Text |
id | pubmed-8694638 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Royal Society of Chemistry |
record_format | MEDLINE/PubMed |
spelling | pubmed-86946382022-04-13 Retraction: Aclarubicin regulates glioma cell growth and DNA damage through the SIRT1/PI3K/AKT signaling pathway Fisher, Laura RSC Adv Chemistry Retraction of ‘Aclarubicin regulates glioma cell growth and DNA damage through the SIRT1/PI3K/AKT signaling pathway’ by Jun-Feng Huo et al., RSC Adv., 2019, 9, 28775–28782, DOI: 10.1039/C9RA05572J. The Royal Society of Chemistry 2021-01-26 /pmc/articles/PMC8694638/ /pubmed/35427023 http://dx.doi.org/10.1039/d1ra90038b Text en This journal is © The Royal Society of Chemistry https://creativecommons.org/licenses/by/3.0/ |
spellingShingle | Chemistry Fisher, Laura Retraction: Aclarubicin regulates glioma cell growth and DNA damage through the SIRT1/PI3K/AKT signaling pathway |
title | Retraction: Aclarubicin regulates glioma cell growth and DNA damage through the SIRT1/PI3K/AKT signaling pathway |
title_full | Retraction: Aclarubicin regulates glioma cell growth and DNA damage through the SIRT1/PI3K/AKT signaling pathway |
title_fullStr | Retraction: Aclarubicin regulates glioma cell growth and DNA damage through the SIRT1/PI3K/AKT signaling pathway |
title_full_unstemmed | Retraction: Aclarubicin regulates glioma cell growth and DNA damage through the SIRT1/PI3K/AKT signaling pathway |
title_short | Retraction: Aclarubicin regulates glioma cell growth and DNA damage through the SIRT1/PI3K/AKT signaling pathway |
title_sort | retraction: aclarubicin regulates glioma cell growth and dna damage through the sirt1/pi3k/akt signaling pathway |
topic | Chemistry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694638/ https://www.ncbi.nlm.nih.gov/pubmed/35427023 http://dx.doi.org/10.1039/d1ra90038b |
work_keys_str_mv | AT fisherlaura retractionaclarubicinregulatesgliomacellgrowthanddnadamagethroughthesirt1pi3kaktsignalingpathway |